← Leaderboards
Nobuyuki Ishibashi
Children'S Research Institute
$9,510,368
Attributed
$11,327,700
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2018–25$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,327,700 · 4
By mechanism
R01$8,275,692 · 2
R33$2,561,133 · 1
R21$490,875 · 1
Top collaborators
- Catherine Mary Bollard3 shared
- Tarik F Haydar2 shared
- Richard A Jonas2 shared
Most similar at Children'S Research Institute
Same institution · by research overlap
- Joseph Scafidi$4,106,734
- Leigh Sepeta$912,200
- Catherine Mary Bollard$14,999,215
- Ljubica Morizono Caldovic$2,687,852
- Nicholas Ah Mew$1,161,811
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsBrainChildCardiac Surgery ProceduresWhite MatterNeurologicClinical TrialsIn UteroCardiopulmonary BypassOperative Surgical ProceduresCongenital Heart DisorderOxygenOligodendrogliaImpairmentHypoxiaNeonatalBrain InjuriesDesignSafetyClinical ResearchMolecularDoseNeuroprotectionNeuroglia
Grant awards (18)
Cell Therapy for Neuroprotection in Congenital Heart Disease$735,704
R01 · FY2025 · HL · contact PI
Cell Therapy for Neuroprotection in Congenital Heart Disease$811,488
R01 · FY2024 · HL · contact PI
Cell Therapy for Neuroprotection in Congenital Heart Disease$837,153
R01 · FY2023 · HL · contact PI
White Matter Protection in the Fetus with Congenital Heart Disease$795,473
R01 · FY2023 · HL · contact PI
The developmental origins and fate of neurons in the gyrencephalic neocortex$223,125
R21 · FY2023 · NS · contact PI
White Matter Protection in the Fetus with Congenital Heart Disease$804,398
R01 · FY2022 · HL · contact PI
The developmental origins and fate of neurons in the gyrencephalic neocortex$267,750
R21 · FY2022 · NS · contact PI
White Matter Protection in the Fetus with Congenital Heart Disease$18,576
R01 · FY2022 · HL · contact PI
Mesenchymal Stromal Cell Delivery through Cardiopulmonary Bypass in Pediatric Cardiac Surgery$813,164
R33 · FY2021 · HL · contact PI
White Matter Protection in the Fetus with Congenital Heart Disease$804,055
R01 · FY2021 · HL · contact PI
Cell Therapy for Neuroprotection in Congenital Heart Disease$645,834
R01 · FY2021 · HL · contact PI
White Matter Protection in the Fetus with Congenital Heart Disease$37,485
R01 · FY2021 · HL · contact PI
Mesenchymal Stromal Cell Delivery through Cardiopulmonary Bypass in Pediatric Cardiac Surgery$866,762
R33 · FY2020 · HL
White Matter Protection in the Fetus with Congenital Heart Disease$823,680
R01 · FY2020 · HL · contact PI
Cell Therapy for Neuroprotection in Congenital Heart Disease$645,834
R01 · FY2020 · HL · contact PI
Mesenchymal Stromal Cell Delivery through Cardiopulmonary Bypass in Pediatric Cardiac Surgery$881,207
R33 · FY2019 · HL
Cell Therapy for Neuroprotection in Congenital Heart Disease$648,631
R01 · FY2019 · HL · contact PI
Cell Therapy for Neuroprotection in Congenital Heart Disease$667,381
R01 · FY2018 · HL · contact PI